$AVXL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANAVEX LIFE SCIENCES CORP..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ANAVEX LIFE SCIENCES CORP.. Get notifications about new insider transactions in ANAVEX LIFE SCIENCES CORP. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Option Exercise | M | 3.28 | 100,000 | 328,000 | 0 | |
| Feb 26 2021 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Option Exercise | M | 2.58 | 45,500 | 117,390 | 0 | |
| Feb 26 2021 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Sell | S | 12.66 | 145,500 | 1,841,855 | 0 | 145.5 K to 0 (-100.00 %) |
| Feb 26 2021 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Buy | M | 3.28 | 100,000 | 328,000 | 145,000 | 45 K to 145 K (+222.22 %) |
| Feb 26 2021 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Buy | M | 2.58 | 45,500 | 117,390 | 45,000 | -500 to 45 K (-9,100.00 %) |
| Feb 23 2021 | AVXL | ANAVEX LIFE SCIENC ... | Donhauser Peter D.O. | Director | Buy | P | 12.97 | 165 | 2,140 | 1,165 | 1,000 to 1.2 K (+16.50 %) |
| Feb 23 2021 | AVXL | ANAVEX LIFE SCIENC ... | Donhauser Peter D.O. | Director | Buy | P | 12.62 | 1,000 | 12,620 | 1,000 | 0 to 1,000 |
| Jan 04 2021 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | Director | Option Exercise | A | 5.49 | 35,000 | 192,150 | 35,000 | |
| Jan 04 2021 | AVXL | ANAVEX LIFE SCIENC ... | Thomas Steffen | Director | Option Exercise | A | 5.49 | 35,000 | 192,150 | 35,000 | |
| Jan 04 2021 | AVXL | ANAVEX LIFE SCIENC ... | Boenisch Sandra | PFO and Treasurer | Option Exercise | A | 5.49 | 50,000 | 274,500 | 50,000 | |
| Jan 04 2021 | AVXL | ANAVEX LIFE SCIENC ... | Donhauser Peter D.O. | Director | Option Exercise | A | 5.49 | 35,000 | 192,150 | 35,000 | |
| Jan 04 2021 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Option Exercise | A | 5.49 | 35,000 | 192,150 | 35,000 | |
| Jan 04 2021 | AVXL | ANAVEX LIFE SCIENC ... | Velden Claus Vander | Director | Option Exercise | A | 5.49 | 35,000 | 192,150 | 35,000 | |
| Jan 04 2021 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Option Exercise | A | 5.49 | 550,000 | 3,019,500 | 550,000 | |
| Jan 08 2020 | AVXL | ANAVEX LIFE SCIENC ... | Boenisch Sandra | PFO & Treasurer | Option Exercise | A | 2.96 | 70,000 | 207,200 | 70,000 | |
| Jan 08 2020 | AVXL | ANAVEX LIFE SCIENC ... | Velden Claus Vander | Director | Option Exercise | A | 2.96 | 50,000 | 148,000 | 50,000 | |
| Jan 08 2020 | AVXL | ANAVEX LIFE SCIENC ... | Thomas Steffen | Director | Option Exercise | A | 2.96 | 50,000 | 148,000 | 50,000 | |
| Jan 08 2020 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Option Exercise | A | 2.96 | 550,000 | 1,628,000 | 550,000 | |
| Jan 08 2020 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Option Exercise | A | 2.96 | 50,000 | 148,000 | 50,000 | |
| Jan 08 2020 | AVXL | ANAVEX LIFE SCIENC ... | Donhauser Peter D.O. | Director | Option Exercise | A | 2.96 | 50,000 | 148,000 | 50,000 | |
| Jan 08 2020 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | Director | Option Exercise | A | 2.96 | 50,000 | 148,000 | 50,000 | |
| Jun 06 2019 | AVXL | ANAVEX LIFE SCIENC ... | Boenisch Sandra | PFO & Treasurer | Option Exercise | A | 2.93 | 35,000 | 102,550 | 35,000 | |
| May 07 2019 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Option Exercise | A | 3.15 | 750,000 | 2,362,500 | 750,000 | |
| Oct 09 2018 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | Director | Option Exercise | A | 2.58 | 45,500 | 117,390 | 45,500 | |
| Oct 03 2018 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Option Exercise | A | 2.58 | 45,500 | 117,390 | 45,500 | |
| Oct 03 2018 | AVXL | ANAVEX LIFE SCIENC ... | Velden Claus Vander | Director | Option Exercise | A | 2.58 | 45,500 | 117,390 | 45,500 | |
| Oct 03 2018 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Option Exercise | A | 2.58 | 409,500 | 1,056,510 | 409,500 | |
| Oct 03 2018 | AVXL | ANAVEX LIFE SCIENC ... | Thomas Steffen | Director | Option Exercise | A | 2.58 | 45,500 | 117,390 | 45,500 | |
| Oct 03 2018 | AVXL | ANAVEX LIFE SCIENC ... | Boenisch Sandra | PFO & Treasurer | Option Exercise | A | 2.58 | 27,300 | 70,434 | 27,300 | |
| Oct 03 2018 | AVXL | ANAVEX LIFE SCIENC ... | Donhauser Peter D.O. | Director | Option Exercise | A | 2.58 | 45,500 | 117,390 | 45,500 | |
| May 17 2018 | AVXL | ANAVEX LIFE SCIENC ... | Boenisch Sandra | PFO & Treasurer | Option Exercise | A | 2.30 | 30,000 | 69,000 | 30,000 | |
| May 17 2018 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Option Exercise | A | 2.30 | 450,000 | 1,035,000 | 450,000 | |
| Mar 09 2018 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 2.92 | 1,360 | 3,971 | 1,018,210 | 1 M to 1 M (+0.13 %) |
| Mar 07 2018 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 2.73 | 1,450 | 3,959 | 1,016,850 | 1 M to 1 M (+0.14 %) |
| Mar 06 2018 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 2.63 | 1,500 | 3,945 | 1,015,400 | 1 M to 1 M (+0.15 %) |
| Mar 05 2018 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | Director, President ... | Buy | P | 2.41 | 1,650 | 3,977 | 1,013,900 | 1 M to 1 M (+0.16 %) |
| Dec 15 2017 | AVXL | ANAVEX LIFE SCIENC ... | Boenisch Sandra | PFO & Treasurer | Option Exercise | A | 3.30 | 30,000 | 99,000 | 30,000 | |
| Dec 15 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Option Exercise | A | 3.30 | 400,000 | 1,320,000 | 400,000 | |
| Oct 26 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.39 | 375 | 1,646 | 1,012,250 | 1 M to 1 M (+0.04 %) |
| Oct 24 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.92 | 375 | 1,845 | 1,011,875 | 1 M to 1 M (+0.04 %) |
| Oct 19 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.49 | 375 | 1,684 | 1,011,500 | 1 M to 1 M (+0.04 %) |
| Oct 18 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.27 | 375 | 1,601 | 1,011,125 | 1 M to 1 M (+0.04 %) |
| Oct 16 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.22 | 750 | 3,165 | 1,010,750 | 1 M to 1 M (+0.07 %) |
| Oct 05 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.30 | 375 | 1,613 | 1,010,000 | 1 M to 1 M (+0.04 %) |
| Oct 02 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.20 | 375 | 1,575 | 1,009,625 | 1 M to 1 M (+0.04 %) |
| Sep 29 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.21 | 375 | 1,579 | 1,009,250 | 1 M to 1 M (+0.04 %) |
| Sep 26 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 3.88 | 375 | 1,455 | 1,008,875 | 1 M to 1 M (+0.04 %) |
| Sep 20 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.23 | 375 | 1,586 | 1,008,500 | 1 M to 1 M (+0.04 %) |
| Sep 19 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.40 | 375 | 1,650 | 1,008,125 | 1 M to 1 M (+0.04 %) |
| Sep 14 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.58 | 375 | 1,718 | 1,007,750 | 1 M to 1 M (+0.04 %) |
| Sep 11 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.81 | 375 | 1,804 | 1,007,375 | 1 M to 1 M (+0.04 %) |
| Sep 08 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.76 | 375 | 1,785 | 1,007,000 | 1 M to 1 M (+0.04 %) |
| Sep 05 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.90 | 375 | 1,838 | 1,006,625 | 1 M to 1 M (+0.04 %) |
| Aug 31 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.48 | 375 | 1,680 | 1,006,250 | 1 M to 1 M (+0.04 %) |
| Aug 29 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.44 | 375 | 1,665 | 1,005,875 | 1 M to 1 M (+0.04 %) |
| Aug 25 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.54 | 375 | 1,703 | 1,005,500 | 1 M to 1 M (+0.04 %) |
| Aug 21 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 4.07 | 375 | 1,526 | 1,005,125 | 1 M to 1 M (+0.04 %) |
| Aug 18 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 3.81 | 375 | 1,429 | 1,004,750 | 1 M to 1 M (+0.04 %) |
| Aug 14 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 3.70 | 375 | 1,388 | 1,004,375 | 1 M to 1 M (+0.04 %) |
| Aug 11 2017 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President and CEO | Buy | P | 3.55 | 750 | 2,663 | 1,004,000 | 1 M to 1 M (+0.07 %) |
| Sep 26 2016 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Option Exercise | A | 3.28 | 100,000 | 328,000 | 100,000 | |
| Sep 26 2016 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | Director | Option Exercise | A | 3.28 | 100,000 | 328,000 | 100,000 | |
| Sep 26 2016 | AVXL | ANAVEX LIFE SCIENC ... | METZNER BERND | Director | Option Exercise | A | 3.28 | 100,000 | 328,000 | 100,000 | |
| Sep 26 2016 | AVXL | ANAVEX LIFE SCIENC ... | Thomas Steffen | Director | Option Exercise | A | 3.28 | 100,000 | 328,000 | 100,000 | |
| Sep 26 2016 | AVXL | ANAVEX LIFE SCIENC ... | Boenisch Sandra | Principal Financial ... | Option Exercise | A | 3.28 | 106,696 | 349,963 | 106,696 | |
| Sep 26 2016 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO & Tr ... | Option Exercise | A | 3.28 | 500,000 | 1,640,000 | 500,000 | |
| Jul 19 2016 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO & Tr ... | Option Exercise | A | 7.06 | 861,429 | 6,081,689 | 861,429 | |
| Jul 19 2016 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO & Tr ... | Option Exercise | A | 6.26 | 379,625 | 2,376,453 | 379,625 | |
| Jul 05 2016 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Option Exercise | A | 6.11 | 1,500 | 9,165 | 1,500 | |
| May 02 2016 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Option Exercise | A | 5.66 | 1,500 | 8,490 | 1,500 | |
| May 02 2016 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Option Exercise | A | 4.90 | 1,500 | 7,350 | 1,500 | |
| Feb 23 2016 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Option Exercise | A | 1.68 | 4,500 | 7,560 | 92,000 | |
| Feb 23 2016 | AVXL | ANAVEX LIFE SCIENC ... | FAVUS ELLIOT | Director | Option Exercise | A | 0.92 | 50,000 | 46,000 | 87,500 | |
| Apr 18 2016 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | Director | Option Exercise | A | 0.92 | 50,000 | 46,000 | 50,000 | |
| Apr 18 2016 | AVXL | ANAVEX LIFE SCIENC ... | METZNER BERND | Director | Option Exercise | A | 0.92 | 50,000 | 46,000 | 87,500 | |
| Jul 14 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO, CFO ... | Buy | P | 0.52 | 1,000 | 518 | 4,013,000 | 4 M to 4 M (+0.02 %) |
| Jul 14 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO, CFO ... | Buy | P | 0.53 | 1,000 | 530 | 4,012,000 | 4 M to 4 M (+0.02 %) |
| Jul 07 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO, CFO ... | Buy | P | 0.51 | 1,000 | 510 | 4,011,000 | 4 M to 4 M (+0.02 %) |
| Jul 07 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO, CFO ... | Buy | P | 0.47 | 1,000 | 470 | 4,010,000 | 4 M to 4 M (+0.02 %) |
| Jul 01 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO, CFO ... | Buy | P | 0.45 | 1,000 | 455 | 3,009,000 | 3 M to 3 M (+0.03 %) |
| Jul 01 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO, CFO ... | Buy | P | 0.44 | 1,000 | 445 | 3,008,000 | 3 M to 3 M (+0.03 %) |
| Jun 23 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO, CFO ... | Buy | P | 0.47 | 1,000 | 468 | 3,007,000 | 3 M to 3 M (+0.03 %) |
| Jun 22 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO, CFO ... | Buy | P | 0.42 | 1,000 | 415 | 3,006,000 | 3 M to 3 M (+0.03 %) |
| Jun 16 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO, CFO ... | Buy | P | 0.44 | 1,000 | 442 | 3,005,000 | 3 M to 3 M (+0.03 %) |
| Jun 15 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President, CEO, CFO ... | Buy | P | 0.43 | 1,000 | 428 | 3,004,000 | 3 M to 3 M (+0.03 %) |
| Jun 12 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President,CEO,CFO & ... | Buy | P | 0.36 | 1,000 | 355 | 3,003,000 | 3 M to 3 M (+0.03 %) |
| Jun 09 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President,CEO,CFO & ... | Buy | P | 0.35 | 1,000 | 352 | 3,002,000 | 3 M to 3 M (+0.03 %) |
| Jun 05 2015 | AVXL | ANAVEX LIFE SCIENC ... | MISSLING CHRISTOPHER U | President,CEO,CFO & ... | Buy | P | 0.37 | 1,000 | 369 | 3,001,000 | 3 M to 3 M (+0.03 %) |
| Dec 04 2013 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | Director | Gift | G | 0.00 | 300,000 | 0 | 5,225,832 | 5.5 M to 5.2 M (-5.43 %) |
| Nov 05 2013 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | Director | Gift | G | 0.00 | 200,000 | 0 | 5,525,832 | 5.7 M to 5.5 M (-3.49 %) |
| Nov 05 2013 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | Director | Gift | G | 0.00 | 1,000,000 | 0 | 5,725,832 | 6.7 M to 5.7 M (-14.87 %) |
| May 29 2012 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President COO Secre ... | Sell | S | 1.05 | 8,572 | 9,001 | 550,000 | 558.6 K to 550 K (-1.53 %) |
| May 29 2012 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President COO Secre ... | Sell | S | 0.80 | 10,000 | 8,000 | 558,572 | 568.6 K to 558.6 K (-1.76 %) |
| Feb 10 2012 | AVXL | ANAVEX LIFE SCIENC ... | TIDMARSH GEORGE F | Executive Director | Option Exercise | J | 2.00 | 4,000 | 8,000 | 4,000 | |
| Feb 10 2012 | AVXL | ANAVEX LIFE SCIENC ... | TIDMARSH GEORGE F | Executive Director | Buy | J | 1.25 | 8,000 | 10,000 | 8,000 | 0 to 8 K |
| Jun 16 2011 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President COO Secre ... | Sell | S | 2.81 | 3,000 | 8,430 | 568,572 | 571.6 K to 568.6 K (-0.52 %) |
| Jun 16 2011 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President COO Secre ... | Sell | S | 2.84 | 3,000 | 8,520 | 571,572 | 574.6 K to 571.6 K (-0.52 %) |
| Jun 16 2011 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President COO Secre ... | Sell | S | 2.90 | 3,200 | 9,280 | 574,572 | 577.8 K to 574.6 K (-0.55 %) |
| Jun 16 2011 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President COO Secre ... | Sell | S | 3.05 | 2,100 | 6,405 | 577,772 | 579.9 K to 577.8 K (-0.36 %) |
| Apr 18 2011 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President COO Secre ... | Sell | S | 2.75 | 10,000 | 27,500 | 579,872 | 589.9 K to 579.9 K (-1.70 %) |
| Mar 14 2011 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President COO Secre ... | Sell | S | 3.68 | 5,500 | 20,240 | 589,872 | 595.4 K to 589.9 K (-0.92 %) |
| Feb 23 2011 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President COO Secre ... | Sell | S | 3.74 | 1,628 | 6,089 | 595,372 | 597 K to 595.4 K (-0.27 %) |
| Feb 23 2011 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President COO Secre ... | Sell | S | 3.75 | 3,000 | 11,250 | 597,000 | 600 K to 597 K (-0.50 %) |
| Sep 29 2010 | AVXL | ANAVEX LIFE SCIENC ... | Tousley David L. | Director | Option Exercise | A | 3.45 | 200,000 | 690,000 | 400,000 | |
| Jul 02 2010 | AVXL | ANAVEX LIFE SCIENC ... | Tousley David L. | Director | Option Exercise | A | 3.50 | 50,000 | 175,000 | 200,000 | |
| Jul 02 2010 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President CEO CFO | Option Exercise | A | 3.50 | 50,000 | 175,000 | 200,000 | |
| Jul 02 2010 | AVXL | ANAVEX LIFE SCIENC ... | Durrant Cameron | Director | Option Exercise | A | 3.50 | 50,000 | 175,000 | 1,000,000 | |
| Jul 02 2010 | AVXL | ANAVEX LIFE SCIENC ... | Ayers Alison E. | Director | Option Exercise | A | 3.50 | 50,000 | 175,000 | 200,000 | |
| Nov 20 2009 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | 10% Owner | Sell | S | 2.25 | 111,112 | 250,002 | 6,725,832 | 6.8 M to 6.7 M (-1.63 %) |
| Nov 20 2009 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | 10% Owner | Sell | S | 2.25 | 111,112 | 250,002 | 6,836,944 | 6.9 M to 6.8 M (-1.60 %) |
| Nov 20 2009 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | 10% Owner | Sell | S | 2.25 | 619,444 | 1,393,749 | 6,948,056 | 7.6 M to 6.9 M (-8.19 %) |
| Jun 19 2009 | AVXL | ANAVEX LIFE SCIENC ... | Durrant Cameron | Director | Option Exercise | A | 2.50 | 400,000 | 1,000,000 | 950,000 | |
| Jun 19 2009 | AVXL | ANAVEX LIFE SCIENC ... | Durrant Cameron | Director | Option Exercise | A | 5.25 | 400,000 | 2,100,000 | 550,000 | |
| Jun 19 2009 | AVXL | ANAVEX LIFE SCIENC ... | Durrant Cameron | Director | Sell | J | 0.00 | 75,000 | 0 | 0 | 75 K to 0 (-100.00 %) |
| Jun 04 2008 | AVXL | ANAVEX LIFE SCIENC ... | Ayers Alison E. | Director | Option Exercise | A | 5.00 | 150,000 | 750,000 | 150,000 | |
| Jun 04 2008 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President, CFO | Option Exercise | A | 5.00 | 150,000 | 750,000 | 150,000 | |
| Oct 31 2007 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | 10% Owner | Sell | S | 1.70 | 950,000 | 1,615,000 | 7,567,500 | 8.5 M to 7.6 M (-11.15 %) |
| Sep 25 2007 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | 10% Owner | Buy | P | 3.60 | 92,500 | 333,000 | 8,517,500 | 8.4 M to 8.5 M (+1.10 %) |
| Aug 07 2007 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | 10% Owner | Sell | S | 1.70 | 950,000 | 1,615,000 | 8,425,000 | 9.4 M to 8.4 M (-10.13 %) |
| Feb 21 2007 | AVXL | ANAVEX LIFE SCIENC ... | Vernadaki Angela | VP Business Develop ... | Option Exercise | P | 3.00 | 150,000 | 450,000 | 150,000 | |
| Feb 21 2007 | AVXL | ANAVEX LIFE SCIENC ... | Kontzalis Panos | CEO | Option Exercise | P | 3.00 | 200,000 | 600,000 | 200,000 | |
| Feb 21 2007 | AVXL | ANAVEX LIFE SCIENC ... | Kalkanis George | VP Strategic Planni ... | Option Exercise | P | 3.00 | 150,000 | 450,000 | 150,000 | |
| Jun 14 2006 | AVXL | ANAVEX LIFE SCIENC ... | Lalach Harvey | President & CEO | Buy | J | 0.00 | 500,000 | 0 | 600,000 | 100 K to 600 K (+500.00 %) |
| Jun 14 2006 | AVXL | ANAVEX LIFE SCIENC ... | Skarpelos Athanasios | 10% Owner | Buy | J | 0.00 | 7,812,500 | 0 | 9,375,000 | 1.6 M to 9.4 M (+500.00 %) |
| Apr 26 2006 | AVXL | ANAVEX LIFE SCIENC ... | Wu Yang | President & CEO | Sell | S | 0.15 | 812,500 | 121,875 | 0 | 812.5 K to 0 (-100.00 %) |
| Apr 26 2006 | AVXL | ANAVEX LIFE SCIENC ... | Wu Pei Ru | COO | Sell | S | 0.15 | 850,000 | 127,500 | 0 | 850 K to 0 (-100.00 %) |
Page: 1